This email was sent on behalf of Ascendis Pharma Endocrinology, Inc.
212 Carnegie Center, Princeton, NJ 08540 US.
If you would like to no longer receive further communications from Ascendis Pharma, please click here:
Unsubscribe
Privacy Policy.
This information is intended for United States residents only. The content of this may not apply to non-US audience as regulatory control, legal requirements, and/or medical practices may vary in other countries.
© March 2026 Ascendis Pharma Endocrinology, Inc. All rights reserved. YORVIPATH®, TransCon®, Ascendis Signature Access Program®, Ascendis®, the Ascendis Pharma logo and the company logo are trademarks owned by the Ascendis Pharma Group.
US-COMMPTH-2500285 3/2026